Table 1 Demographic and clinical characteristics of follow-up COVID-19 patients
From: Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients
Characteristics | COVID-19 follow-up patients | P | |
|---|---|---|---|
Category (n) | Mild (59) | Severe/Critical (48) | |
Age, years | 65 (51, 69) | 66 (62, 74) | n.s. |
Male | 28 (47%) | 25 (52%) | n.s. |
Female | 31 (53%) | 23 (48%) | n.s. |
Comorbidities | |||
2-DM | 6 (10%) | 6 (12%) | n.s. |
Hypertension | 21 (36%) | 23 (48%) | n.s. |
CVD | 6 (10%) | 8 (16%) | n.s. |
Gastrointestinal diseases | 4 (7%) | 2 (4%) | n.s. |
Follow-up (days) | 93 (82, 96) | 101 (96, 118) | n.s. |
Cholesterol-lowering drugs | 9 (15%) | 7 (18%) | n.s. |